Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Preventability of some hospital-acquired conditions questioned
CHICAGO — Hospital-acquired conditions that patients developed after surgical resection for cancer may be linked to preoperative comorbidities in some cases, and they may negatively affect provider payments dictated by CMS, researchers said at Digestive Disease Week 2014.
Surgical management of colorectal adenocarcinoma unchanged by PET/CT use
The use of PET/CT vs. CT alone did not significantly change the surgical treatment in patients with potentially resectable hepatic metastases of colorectal adenocarcinoma.
Log in or Sign up for Free to view tailored content for your specialty!
Surgery plus intraperitoneal chemotherapy improved long-term survival in abdominal cancer
For appropriately selected patients with peritoneal dissemination of an abdominal malignancy, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy may offer significant long-term survival.
What is hepatocellular carcinoma?
Hepatocellular carcinoma, also sometimes called hepatoma, is a form of cancer that begins primarily in the liver. It is the most common form of liver cancer, representing about 12,000 cases in the United States annually and 80% of all forms of liver cancers.
Mass screening decreased mortality rate in HCC Taiwanese patients
Participants in a community-based abdominal ultrasonography screening in Taiwan displayed a decreased hepatocellular carcinoma mortality rate, compared with patients who did not undergo the screening, according to recent study data.
Hepatic arterial infusion with cisplatin improved outcomes in early HCC
Hepatic arterial infusion with high-concentration cisplatin before radical local treatment improved survival among patients with early-stage hepatocellular carcinoma, according to study results.
Data suggest HCC incidence in US may have peaked
Driven by declining liver mortality rates among Asians and Pacific Islanders and middle-aged men, incidence rates for hepatocellular cancer did not significantly increase in the US during a recent 11-year period, according to study results.
Adoptive T-cell immunotherapy may treat hepatocellular carcinoma
LONDON — Hepatocellular carcinoma may be treated using adoptive T-cell therapy, according to data from a study presented at the International Liver Congress.
HBV increased cell proliferation during hepatocellular carcinoma
Hepatitis B virus infection enhanced cell proliferation via HBx protein-induced microRNA-21 in hepatocellular carcinoma, according to recent study results.
Novel anti-tumor agent may inhibit cell growth in HCC patients
Hepatocellular carcinoma cell growth in vitro was suppressed by 6-fluoro-3-formylchromone through cell cycle arrest that induced apoptosis, according to data from a recent study.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read